Comparison of survival and hospitalization rates between Medicare patients with advanced NSCLC treated with bevacizumab–carboplatin–paclitaxel and carboplatin–paclitaxel: A retrospective cohort study
Keyword(s):
2020 ◽
Vol 69
(3)
◽
pp. 399-405
◽
Keyword(s):
2022 ◽
Vol Volume 15
◽
pp. 637-644
2020 ◽
Vol Volume 15
◽
pp. 3323-3334
Keyword(s):